Quantcast

Latest Oncothyreon Inc. Stories

2011-03-01 07:05:00

SEATTLE, March 1 /PRNewswire-FirstCall/ - Oncothyreon Inc.

2011-03-01 07:00:00

SEATTLE, March 1 /PRNewswire-FirstCall/ - Oncothyreon Inc.

2011-02-08 07:00:00

SEATTLE, Feb. 8 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the 13(th) Annual BIO CEO & Investor Conference in New York on Tuesday, February 15, 2011, at 1:00 p.m.

2010-12-20 07:00:00

SEATTLE, WA, Dec. 20 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chimeric monoclonal antibody cetuximab (Erbitux(R)).

2010-11-18 07:00:00

SEATTLE, Nov. 18 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) today reported updated results from a Phase 1 clinical trial of PX-866, an irreversible small molecule phosphatidylinositol-3-kinase (PI-3K) inhibitor, in patients with advanced solid tumors.

2010-11-08 15:05:00

SEATTLE, Nov. 8 /PRNewswire-FirstCall/ - Oncothyreon Inc.

2010-11-03 07:00:00

SEATTLE, Nov. 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced enrollment of the first patient in a Phase 1/2 trial of PX-866 in combination with the chemotherapeutic agent docetaxel.

2010-11-01 07:00:00

SEATTLE, Nov. 1 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) will conduct a conference call to discuss its third quarter 2010 financial results and provide a review of its pipeline of products in development on Monday, November 8, 2010 at 4:30 p.m. Eastern time (1:30 p.m.

2010-09-27 07:00:00

SEATTLE, WA, Sept. 27 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will present at the 5th Annual JMP Securities Healthcare Conference in New York on Tuesday, September 28, 2010, at 10:30 a.m.

2010-09-24 07:50:00

SEATTLE, WA, Sept. 24 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY), announced it has entered into a securities purchase agreement in connection with a private placement.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.